Navigation Links
Lifeline Biotechnologies and Depository Trust Company
Date:9/30/2011

RENO, Nev., Sept. 30, 2011 /PRNewswire/ -- Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company continues efforts to reestablish DTC services.

Jim Holmes, Lifeline's CEO said "While our efforts have continued to reestablish DTC's services to the Company we have not been successful.  We now are considering alternatives should the circumstances not change.

The value of Lifeline is not reflected in the current lack of liquidity (low per share market price and low daily volume of shares traded).  Lifeline's investment in First Warning Systems has not diminished; in fact, First Warning's value has appreciated as established milestones have been achieved.  Our focus in First Warning is preparation for the final round of clinical trials estimated to commence in the latter half of 2012.   At this time, our best estimate for trial completion is late 2013. The trails must be successfully completed before our FDA medical device marketing application is submitted in the U.S."

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

CONTACT: Lifeline Biotechnologies, Inc.
Jim Holmes, 775-326-9614    Email: Jh
'/>"/>

SOURCE Lifeline Biotechnologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
2. Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners
3. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
4. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
5. Benjamin Custodio Joins Millennium Biotechnologies to Expand International Sales
6. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
7. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
8. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
9. Andre Marion Joins Microchip Biotechnologies Board of Directors
10. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
11. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... CT (PRWEB) , ... July 29, 2015 , ... ... Biological Industries’ (BI) advanced cell culture products, announces the availability of BI’s line ... launched by Biological Industries, these stem cell differentiation media offer a complete system ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nearly everyone has heard of ... few people realize that a rich source of these cells is teeth—baby teeth that ... that need to be pulled to make room for braces. These potent stem ...
(Date:7/28/2015)... ... , ... Strong Animals™ announced today that research conducted by South Dakota State ... ADSA-ASAS Joint Annual Meeting held July 12-16 in Orlando, FL showed feed additive Stay ... content. Also, feed containing Stay Strong™ for Dairy Cows took longer than 7.7 hours ...
(Date:7/28/2015)... , July 28, 2015  PDL BioPharma, Inc. (PDL, ... that the Company will release its second quarter 2015 ... on Wednesday, August 5, 2015, after market close. PDL,s ... day at 4:30 p.m. Eastern Time to discuss the ... will be available via the webcast link on the ...
Breaking Biology Technology:Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2Strong Animals™ Announces South Dakota State University Research Demonstrates Stay Strong™ for Dairy Cows Improves Performance and Feed Stability 2PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2
... Former U.S. President Bill Clinton will,participate as one of the ... June 1 and 3 in Sao Paulo, Brazil. The event ... one of the most,important gatherings focused on biofuels in the ... first Democratic president awarded a second term,in six decades. After ...
... expert in ion channels and GPCRs (G-protein coupled receptors) ... is one of eight organizations slated to receive funding ... Ted Strickland and Interim Director of the Ohio Department ... Commission, Mark Barbash, announced the competitive grants last week, ...
... May 6 SpectraScience, Inc. (OTC Bulletin ... company, today announced that The Wall Street ... Chief Executive Officer Jim Hitchin. The interview, ... company,s website at http://www.spectrascience.com/tinymce/jscripts/tiny_mce/plugins/ajaxfilemanager/uploaded/Wall%20Street%20Transcript.pdf Mr. ...
Cached Biology Technology:President Bill Clinton to Speak at the Ethanol Summit in Brazil 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript 2SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript 3
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... mobile commerce market announces a revised version of one of its ... will air on CNBC in New York , ... and San Francisco metro areas.    ... Wocket,s ability to replace all the cards in your wallet and ...
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... Pennsylvania State University College of Medicine, Hershey, Pennsylvania have ... growth factor receptor (OGFr), which mediates the inhibitory action ... a key to understanding the progression and treatment of ... cells that were molecularly engineered to have a reduced ...
... A small population of rattlesnakes that already is ... unexpected threat in the form of a fungus rarely ... reports of rattlesnake deaths in the northeast United States. ... catenatus ), a candidate for protection under the federal ...
... receptive to donating blood or other genetic material for scientific ... Dallas. In what appears to be the first study ... biobank, the study surveyed 250 male and female undergraduate and ... they were willing to donate to a biobank, said study ...
Cached Biology News:A breakthrough in understanding the biology and treatment of ovarian cancer 2A breakthrough in understanding the biology and treatment of ovarian cancer 3Rare fungus kills endangered rattlesnakes in southern Illinois 2Study finds college students willing to donate genetic material to biobanks for research 2
Recombinant Feline IL-12/IL-23 p40 (C-Terminus), CF...
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
... Butcher (1998). • The major histocompatibility complex ... the immunology area. There is great interest ... in their function as antigen-presenting molecules. Many ... prospect of tackling biochemical and genetic techniques ...
Biology Products: